Idenix Pharmaceuticals (IDIX) Soars Almost 240 percent

Shares of Idenix Pharmaceuticals Inc (IDIX) are up nearly 234% at time of writing to $24.15 after announcing Merck (MRK) will buy the company for $3.85 billion. The deal values Idenix $24.50 per share, which is more than 3X Idenix’s Friday closing price of $7.23. The boards of both companies have approved the deal and […] View the full post at: Idenix Pharmaceuticals (IDIX) Soars Almost 240 percent Related posts: Walt Disney to Acquire Marvel Entertainment for $4B TiVo’s Patent Holds, Stock Soars, Commercials Skipped Toshiba to Buy 30 Percent Stake in SanDisk